Equities Research Analysts’ Upgrades for March 25th (AMN, COF, CRWD, CVNA, EQT, ESRT, FLR, HQY, IBKR, INDB)
Equities Research Analysts’ upgrades for Tuesday, March 25th: AMN Healthcare Services (NYSE:AMN) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. Capital One Financial (NYSE:COF) was upgraded by analysts at BTIG Research from a neutral rating to a buy rating. BTIG Research currently has $208.00 price target on the stock. […]
25 Mar 17:48 · The Markets Daily
Stock Analysts’ Upgrades for March 24th (ABEO, BWA, CEVA, FIVE, INVA, IOSP, ISSC, JHX, LMT, SOHU)
Stock Analysts’ upgrades for Monday, March 24th: Abeona Therapeutics (NASDAQ:ABEO) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. BorgWarner (NYSE:BWA) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. CEVA (NASDAQ:CEVA) was upgraded by analysts at StockNews.com from a hold rating to a buy […]
24 Mar 23:48 · The Cerbat Gem
Investment Analysts’ Updated EPS Estimates for March 25th (ABDP, AG, AKYA, ALIT, ANIX, ARTV, ASB, ATNM, AZEK, BAG)
Investment Analysts’ updated eps estimates for Tuesday, March 25th: AB Dynamics (LON:ABDP) had its buy rating reaffirmed by analysts at Shore Capital. AG.L (LON:AG) had its house stock rating reaffirmed by analysts at Shore Capital. Akoya Biosciences (NASDAQ:AKYA) had its equal weight rating reiterated by analysts at Stephens. They currently have a $1.80 price target […]
25 Mar 13:48 · The Cerbat Gem
last updated on 26 Mar 08:45